Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.20 +0.00 (+0.00%)
As of: Oct 21, 2026 · 3:59 PM EDT

Eloxx Pharmaceuticals (ELOX) Deferred Taxes (2016)

Updated

Eloxx Pharmaceuticals' Deferred Taxes was -$1.04 million in FY2017.

Analysis

Eloxx Pharmaceuticals (ELOX) Deferred Taxes (2016) Analysis & Trends

  • Per Business Quant data, Deferred Taxes in earlier years was -$1.04 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 Eloxx Pharmaceuticals 89.68 Mn 16.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -640,000.00
API Access

Eloxx Pharmaceuticals Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ELOX&period=max&api_key=YOUR_API_KEY